Christina Junvik

I bring more than 20 years of hands-on drug development experience across biotech, pharma, and CROs, with a strong focus on early-stage development. My core expertise is in clinical and regulatory development, but I take a holistic view of programs, connecting the science, nonclinical package, clinical strategy, regulatory requirements, and operational realities to identify what is needed to move an asset forward.

I am particularly well suited to advising small, science-driven biotech companies transitioning from preclinical development into first-in-human and early clinical development. My strongest therapeutic experience is in oncology, with additional experience in rare diseases and advanced therapies.

Through many years in drug development, I have also built a network of experienced professionals across different development disciplines and can make relevant connections when appropriate.